ID   ScN2a
AC   CVCL_6268
DR   BTO; BTO:0003716
DR   ChEMBL-Cells; CHEMBL3308084
DR   ChEMBL-Targets; CHEMBL613872
DR   PubChem_Cell_line; CVCL_6268
DR   Wikidata; Q54952480
RX   PubMed=10756052;
RX   PubMed=17850126;
CC   Characteristics: Infected with mouse RML strain prions.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=10756052; DOI=10.1128/JVI.74.9.4377-4386.2000;
RA   Bosque P.J., Prusiner S.B.;
RT   "Cultured cell sublines highly susceptible to prion infection.";
RL   J. Virol. 74:4377-4386(2000).
//
RX   PubMed=17850126; DOI=10.1021/jm070688r;
RA   Kimata A., Nakagawa H., Ohyama R., Fukuuchi T., Ohta S., Doh-ura K.,
RA   Suzuki T., Miyata N.;
RT   "New series of antiprion compounds: pyrazolone derivatives have the
RT   potent activity of inhibiting protease-resistant prion protein
RT   accumulation.";
RL   J. Med. Chem. 50:5053-5056(2007).
//